NQO Antibodies

Santa Cruz Biotechnology provides a broad selection of NQO Antibodies for a variety of research applications. NQO Antibodies are validated for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NQO, or NAD(P)H:quinone oxidoreductase, plays a crucial role in cellular defense against oxidative stress by catalyzing the reduction of quinones to less harmful compounds. NQO is instrumental in the detoxification of reactive oxygen species and has been implicated in various diseases, including cancer and neurodegenerative disorders. Understanding the function and regulation of NQO is essential for developing therapeutic strategies targeting oxidative stress-related conditions. Research into NQO expression patterns can reveal valuable information about cellular responses to oxidative stress. Investigating NQO activity helps scientists understand its protective mechanisms in different tissue types. Exploring NQO regulation provides insights into potential therapeutic interventions for oxidative stress-related diseases. Santa Cruz Biotechnology monoclonal antibodies for NQO research support scientists worldwide in advancing our understanding of oxidative stress and its impact on human health.